Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
TRIAD - Treatment of Insomnia and Depression
Trial ID or NCT#
NCT00767624
Status
Purpose
The aim of the proposed three-site study is to increase the rate of full remission from major depressive disorder (MDD) at the end of 16 weeks of treatment for people who experience both major depressive disorder and insomnia.
Investigator(s)
Rachel Manber, PhD
Contact us to find out if this trial is right for you.
CONTACT
Haddas Elisha
(650) 723-2641
View on ClinicalTrials.gov
About this Clinical Trial
TRIAD - Treatment of Insomnia and Depression
Your Message Will Go To
Haddas Elisha650-723-2641